These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16687949)

  • 21. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
    Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
    Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.
    Ramchandra R; Watson AM; Hood SG; May CN
    Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1056-60. PubMed ID: 20147604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential clinical profile of candesartan compared to other angiotensin receptor blockers.
    Cernes R; Mashavi M; Zimlichman R
    Vasc Health Risk Manag; 2011; 7():749-59. PubMed ID: 22241949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats.
    Jenkins TL; Coleman AE; Schmiedt CW; Brown SA
    Am J Vet Res; 2015 Sep; 76(9):807-13. PubMed ID: 26309109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.
    Fujino M; Miura S; Kiya Y; Tominaga Y; Matsuo Y; Karnik SS; Saku K
    Hypertens Res; 2010 Oct; 33(10):1044-52. PubMed ID: 20668453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels.
    Pediconi D; Martarelli D; Fontanazza A; Pompei P
    Eur J Pharmacol; 2005 Dec; 528(1-3):79-87. PubMed ID: 16321381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological properties and clinical efficacy of the long-active angiotensin receptor blocker (ARB) irbesartan].
    Ariyoshi Y; Mizumoto K
    Nihon Yakurigaku Zasshi; 2009 May; 133(5):275-80. PubMed ID: 19443965
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
    Maillard MP; Mazzolai L; Daven V; Centeno C; Nussberger J; Brunner HR; Burnier M
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1201-8. PubMed ID: 10619583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
    Ernsberger P; Koletsky RJ
    Curr Opin Pharmacol; 2007 Apr; 7(2):140-5. PubMed ID: 17303473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
    Burnier M; Zanchi A
    J Hypertens; 2006 Jan; 24(1):11-25. PubMed ID: 16331093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
    Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR
    Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling.
    Hines J; Fluharty SJ; Sakai RR
    Eur J Pharmacol; 1999 Nov; 384(1):81-9. PubMed ID: 10611423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay.
    Belz GG; Butzer R; Kober S; Mang C; Mutschler E
    Clin Pharmacol Ther; 1999 Oct; 66(4):367-73. PubMed ID: 10546920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I.
    Puscas I; Coltau M; Gilau L; Baican M; Pasca R; Domuta G; Hecht A
    Int J Clin Lab Res; 2000; 30(3):119-25. PubMed ID: 11196069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.